Literature DB >> 30783966

Design of AAV Vectors for Delivery of Large or Multiple Transgenes.

Aman Patel1, Junling Zhao1, Dongsheng Duan1,2,3,4, Yi Lai5.   

Abstract

Adeno-associated virus (AAV)-mediated gene therapy has evolved from bench to bedside, and now is the therapy of choice for certain inherited diseases. However, the small packaging capacity of AAV vectors prevents this technique from treating genetic diseases with mutations of large genes. Multiple strategies, including split AAV gene delivery and oversized AAV gene delivery, have been explored to deliver large gene expression cassettes. These strategies have gained some success in animal experiments. In this chapter, we review the progress of AAV-mediated delivery of large expression cassettes. We also review using AAV to deliver multiple transgenes.

Entities:  

Keywords:  AAV; Dual vectors; Fragmented AAV gene delivery; Large gene expression cassette; Multiple gene expression cassette; Overlapping AAV vectors; Oversized AAV; Split AAV vectors; Trans-splicing AAV vectors; Triple vectors

Mesh:

Year:  2019        PMID: 30783966     DOI: 10.1007/978-1-4939-9139-6_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Gene therapy for inherited arrhythmias.

Authors:  Vassilios J Bezzerides; Maksymilian Prondzynski; Lucie Carrier; William T Pu
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

Review 2.  Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editors.

Authors:  Paul Boucher; Xiaoxia Cui; David T Curiel
Journal:  J Control Release       Date:  2020-09-03       Impact factor: 9.776

Review 3.  CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors.

Authors:  Dan Wang; Feng Zhang; Guangping Gao
Journal:  Cell       Date:  2020-04-02       Impact factor: 41.582

Review 4.  Molecular Therapies for Inherited Retinal Diseases-Current Standing, Opportunities and Challenges.

Authors:  Irene Vázquez-Domínguez; Alejandro Garanto; Rob W J Collin
Journal:  Genes (Basel)       Date:  2019-08-28       Impact factor: 4.096

Review 5.  Translation of New and Emerging Therapies for Genetic Cardiomyopathies.

Authors:  Adam S Helms; Andrea D Thompson; Sharlene M Day
Journal:  JACC Basic Transl Sci       Date:  2021-12-01

Review 6.  Maybe you can turn me on: CRISPRa-based strategies for therapeutic applications.

Authors:  Elvir Becirovic
Journal:  Cell Mol Life Sci       Date:  2022-02-12       Impact factor: 9.261

Review 7.  Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy.

Authors:  Virginie Mariot; Julie Dumonceaux
Journal:  Front Genome Ed       Date:  2022-07-15

8.  Intramuscular Delivery of Gene Therapy for Targeting the Nervous System.

Authors:  Andrew P Tosolini; James N Sleigh
Journal:  Front Mol Neurosci       Date:  2020-07-17       Impact factor: 5.639

9.  No more helper adenovirus: production of gutless adenovirus (GLAd) free of adenovirus and replication-competent adenovirus (RCA) contaminants.

Authors:  Dongwoo Lee; Jida Liu; Hyun Jung Junn; Eun-Joo Lee; Kyu-Shik Jeong; Dai-Wu Seol
Journal:  Exp Mol Med       Date:  2019-10-28       Impact factor: 8.718

Review 10.  Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions.

Authors:  Saleh Jamehdor; Sara Pajouhanfar; Sadaf Saba; Georges Uzan; Ali Teimoori; Sina Naserian
Journal:  Cells       Date:  2022-03-15       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.